Akanda Corp.

NasdaqCM AKAN

Akanda Corp. Price to Sales Ratio (P/S) on December 30, 2024

Akanda Corp. Price to Sales Ratio (P/S) is NA on December 30, 2024, a NA change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Akanda Corp. 52-week high Price to Sales Ratio (P/S) is 9.78 on January 17, 2024, which is NA below the current Price to Sales Ratio (P/S).
Akanda Corp. 52-week low Price to Sales Ratio (P/S) is 1.11 on June 07, 2024, which is NA below the current Price to Sales Ratio (P/S).
Akanda Corp. average Price to Sales Ratio (P/S) for the last 52 weeks is 3.57.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NasdaqCM: AKAN

Akanda Corp.

CEO	Ms. Katharyn Field
IPO Date	March 15, 2022
Location	United Kingdom
Headquarters	1a, 1b Learoyd Road
Employees	46
Sector	Health Care
Industries Pharmaceuticals

Description

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Key trends

Past 5 years